Expressions of growth-related genes that included cyclin D1 and cyclin-dependent kinase inhibitors were evaluated at the protein and mRNA levels after HCC cells were treated with different concentrations of vitamin K2 ranging from 10–4 to 10–7 M for 48 h. This evidence concerns the gene CCND1 and hepatocellular carcinoma.